Skip to main content
Cresco Labs Inc. logo

Cresco Labs Inc. — Investor Relations & Filings

Ticker · CRLBF ISIN · CA22587M1068 LEI · 549300NSGBTQRF1IBL30 CSE Manufacturing
Open in API
Filings indexed 243 across all filing types
Latest filing 2026-04-23 Regulatory Filings
Country CA Canada
Listing CSE CRLBF

About Cresco Labs Inc.

https://www.crescolabs.com/

Cresco Labs Inc. is a vertically integrated, multistate operator in the cannabis industry, specializing in the cultivation, manufacturing, distribution, and retail sale of medical and adult-use cannabis products. The company manages a portfolio of proprietary brands, including Cresco Cannabis, High Supply, and Mindys Edibles, offering various formats such as flowers, concentrates, and edibles. Cresco Labs distributes its products wholesale and through its national dispensary network, primarily branded Sunnyside, across the United States and Germany. The company focuses on professionalizing the cannabis experience, maintaining high-quality production standards, and promoting industry responsibility through advocacy and community initiatives.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 60% confidence The document is a press release announcing the CEO’s statement on the Department of Justice’s final rule rescheduling medical cannabis. It is not an earnings release, financial report, management change, or any of the specific report types listed. It does not present financial results or solicit shareholder votes, nor is it a presentation or detailed report. Therefore, it falls into the general fallback category for miscellaneous corporate announcements (Regulatory Filings).
2026-04-23 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the date and details of Cresco Labs' upcoming first quarter 2026 financial results report and the associated earnings conference call. It does not contain actual financial data or detailed financial statements but rather informs investors about when and how the results will be released and discussed. The document length is short (2301 characters), and it primarily serves as an announcement rather than the report itself. According to the classification rules, such announcements about upcoming earnings releases and conference calls should be classified as Earnings Release (ER) if they contain key highlights or initial financial results, but since this document only announces the date and call details without any financial results, it fits best as a Regulatory Filings (RNS) or possibly Report Publication Announcement (RPA). However, RPA is typically for announcements about the timing or availability of full reports, not just earnings call announcements. Given the content, the best fit is Regulatory Filings (RNS) as a general announcement about the upcoming earnings release and call without substantive financial data.
2026-04-23 English
News release - English.pdf
Report Publication Announcement Classification · 85% confidence The document is a brief press release (under 5,000 characters) announcing the timing and webcast details for the upcoming first quarter 2026 financial results and associated conference call. No actual financial results or key metrics are provided; rather it simply notifies investors when and how the report will be released. This matches the definition of a Report Publication Announcement (RPA).
2026-04-23 English
News release - English.pdf
Regulatory Filings Classification · 25% confidence The document is a Business Wire press release announcing the opening of a new dispensary location. It does not present financial results, regulatory voting, management changes, or an investor presentation. It is clearly not an Annual or Interim Report, nor an Earnings Release, M&A announcement, or any other specific filing type. Therefore, it falls into the catch-all Regulatory Filings (RNS) category.
2026-04-10 English
News release - English.pdf
Regulatory Filings Classification · 15% confidence The document is a Business Wire press release announcing the grand opening of a new dispensary location. It contains corporate marketing and forward-looking statement boilerplate but no financial results, regulatory form filings, management changes, share transactions, dividends, or other specific filing content. It does not represent an investor presentation, earnings release, or other defined report. Therefore it falls into the fallback category for miscellaneous corporate announcements (Regulatory Filings).
2026-04-10 English
News release - English.pdf
Regulatory Filings Classification · 85% confidence The document is a Business Wire press release announcing that Cresco Labs has been awarded a Texas medical cannabis license. It is not a financial earnings release, annual or interim report, management/transcript, or any detailed investor presentation. It does not fit any specific category such as dividend notice, share issuance, M&A, board changes, or regulatory form disclosures. Therefore, it falls into the fallback category for general regulatory or corporate announcements that do not fit elsewhere: Regulatory Filings (RNS).
2026-04-02 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.